$1.7m fine for misleading painkiller claims
THE company that makes Nurofen analgesics has been ordered to pay a $1.7 million fine for misleading Australian consumers.
Reckitt Benckiser was ordered to pay the penalty in a Federal Court ruling in Brisbane, which was video-linked in Sydney on Friday.
In 2015, the court ruled that the company misled Australian consumers by claiming that identical products were each formulated to target specific types of pain.
Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache all contain the same active ingredient,